More Than 85 Small Molecule Protein Degraders Are Currently Being Evaluated For The Treatment Of Various Disease Indications

By Author: sumanbutler
Total Articles: 9
Comment this article

To order this 330+ page report, which features 130+ figures and 145+ tables, please visit this link

The USD 3.6 billion (by 2030) financial opportunity within the target protein degradation market has been analyzed across the following segments:
 Type of payment of licensing agreements
 Upfront payments
 Milestone payments

 Type of protein degrader
 Degronimids
 PROTACs
 SARDs / SERDs
 Specific BET and DUB inhibitors
 Other protein degraders

 Therapeutic area
 Neurodegenerative disorders
 Oncological disorders
 Other therapeutic areas

 Route of administration
 Oral
 Intravenous
 Other routes

 Key geographical region
 North America
 Europe
 Asia-Pacific

The Targeted Protein Degradation Market: Focus on Therapeutics and Technology Platforms (based on Degronimids, ENDTACs, Epichaperome Inhibitors, Hydrophobic Tags, IMiDs, LYTACs, Molecular Glues, PHOTACs, PROTACs, Protein Homeostatic Modulators, SARDs, SERDs, SNIPERs, and ...
... Specific BET and DUB Inhibitors), 2020-2030 report features the following companies, which we identified to be key players in this domain:
 Arvinas
 Captor Therapeutics
 Celgene
 Genetech
 Kymera Therapeutics
 Mission Therapeutics
 Progenra
 Radius Health
 Sanofi Genzyme
 Zenopharm

To request for sample report – https://www.rootsanalysis.com/reports/289/request-sample.html

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Current Market Landscape

5. Company Profiles

6. Clinical Trial Analysis

7. KOL Analysis

8. Publication Analysis

9. Funding and Investment Analysis

10. Partnerships and Collaborations

11. Market Sizing and Opportunity Analysis

12. Executive Insights

13. Concluding Remarks

14. Appendix 1: Tabulated Data

15. Appendix 2: List of Companies and Organizations

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/protein-degradation-market/289.html

Other Recent Offerings
1. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market (3rd Edition), 2019-2030 (Focus on AAV, Adenoviral, Lentiviral, Retroviral, Plasmid DNA and Other Vectors)
2. CAR-T Therapies Market (2nd Edition), 2019-2030
3. Global T-Cell (CAR-T, TCR, and TIL) Therapy Market (4th Edition), 2019 – 2030

About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
ben.johnson@rootsanalysis.com
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis